Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study

JACC. Cardiovascular Interventions
Patrick GladdingMark Webster

Abstract

Our aim was to assess whether a higher clopidogrel maintenance dose has a greater antiplatelet effect in CYP2C19*2 allele carriers compared with noncarriers. Clopidogrel is a prodrug that is biotransformed by the cytochrome P450 enzymes CYP2C19, 2C9, and 3A4, 2B6, 1A2. The CYPC219*2 loss of function variant has been associated with a reduced antiplatelet response to clopidogrel and a 3-fold risk of stent thrombosis. Forty patients on standard maintenance dosage clopidogrel (75 mg), for 9.4 +/- 9.2 weeks, were enrolled into a dose escalation study. Platelet function was assessed at baseline and after 1 week of 150 mg once daily using the VerifyNow platelet function analyzer (Accumetrics Ltd., San Diego, California). Genomic DNA was hybridized to a BioFilmChip microarray on the INFINITI analyzer (AutoGenomics Inc., Carlsbad, California) and analyzed for the CYP19*2, *4, *17, and CYP2C9*2, *3 polymorphisms. Platelet inhibition increased over 1 week, mean +8.6 +/- 13.5% (p = 0.0003). Carriers of the CYP2C19*2 allele had significantly reduced platelet inhibition at baseline (median 18%, range 0% to 72%) compared with wildtype (wt) (median 59%, range 11% to 95%, p = 0.01) and at 1 week (p = 0.03). CYP2C19*2 allele carriers had an inc...Continue Reading

Associated Clinical Trials

References

Aug 14, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·J GeigerU Walter
Nov 25, 2003·Clinical Chemistry·Larry J KrickaPaolo Fortina
Jan 18, 2005·Journal of the American College of Cardiology·Victor L SerebruanyEric J Topol
Jan 22, 2005·Nucleic Acids Research·Y Paul BaoUwe R Müller
May 7, 2005·PharmacoEconomics·William WeintraubMichel Bertrand
Apr 29, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Dominick J AngiolilloCarlos Macaya
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Nov 9, 2007·Circulation·Jeffrey L AndersonUNKNOWN Couma-Gen Investigators
Feb 5, 2008·Pharmacogenomics·Stuart A ScottRobert J Desnick
May 16, 2008·American Journal of Clinical Pathology·Cristi R KingCharles Eby
Dec 17, 2008·American Heart Journal·Jolanta M Siller-MatulaBernd Jilma
Dec 25, 2008·The New England Journal of Medicine·Tabassome SimonUNKNOWN French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators
Dec 25, 2008·The New England Journal of Medicine·Jessica L MegaMarc S Sabatine
Mar 5, 2009·JAMA : the Journal of the American Medical Association·P Michael HoJohn S Rumsfeld
Mar 10, 2009·The American Journal of Cardiology·Betti GiustiGian Franco Gensini
Apr 1, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Wei C Lau, Paul A Gurbel
Apr 8, 2009·Thrombosis and Haemostasis·Dirk SibbingNicolas von Beckerath
Apr 14, 2009·Current Atherosclerosis Reports·Ali J Marian

❮ Previous
Next ❯

Citations

Apr 13, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Vincent Lai Ming Yip, Munir Pirmohamed
Aug 2, 2011·European Heart Journal·Jeffrey J W VerschurenJ Wouter Jukema
Oct 13, 2010·Pharmacogenetics and Genomics·Katrin SangkuhlRuss B Altman
Apr 12, 2011·Thrombosis and Haemostasis·Liana YukhanyanKurt Huber
Sep 17, 2011·Circulation Research·Dan M RodenRussell A Wilke
Jul 16, 2015·Expert Opinion on Drug Metabolism & Toxicology·Yao YangStuart A Scott
Sep 3, 2011·Drug Discovery Today·Munir Pirmohamed
Oct 3, 2014·Clinical Chemistry and Laboratory Medicine : CCLM·Jian-Min XiaoJia-Wu Song
Mar 10, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Christine C LeeKiang-Teck J Yeo
Mar 4, 2014·Global Public Health·Catherine Olivier, Bryn Williams-Jones
May 24, 2016·Clinical and Translational Science·Meghan J ArwoodJulio D Duarte
Mar 1, 2014·Personalized Medicine·Taylor Sweezy, Shaker A Mousa
Jan 29, 2011·Clinical Pharmacology and Therapeutics·A L BeitelsheesA R Shuldiner
Nov 18, 2020·Pharmacology Research & Perspectives·Bhawani Yasassri AlvitigalaLiyanage Dona Ashanthi Menuka Arawwawala
Oct 11, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Nicola MarzilianoPiera Angelica Merlini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.